Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Healthcare Triangle (HCTI) EBITDA Margin (2020 - 2025)

Healthcare Triangle filings provide 6 years of EBITDA Margin readings, the most recent being 143.29% for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 25776.0% to 143.29% in Q4 2025 year-over-year; TTM through Dec 2025 was 65.82%, a 4621.0% increase, with the full-year FY2025 number at 68.14%, up 4647.0% from a year prior.
  • EBITDA Margin reached 143.29% in Q4 2025 per HCTI's latest filing, down from 54.46% in the prior quarter.
  • The five-year high for EBITDA Margin was 4.68% in Q2 2021, with the low at 401.05% in Q4 2024.
  • A 5-year average of 55.43% and a median of 34.32% in 2021 define the central range for EBITDA Margin.
  • Year-over-year, EBITDA Margin tumbled -38218bps in 2024 and then skyrocketed 25776bps in 2025.
  • Year by year, EBITDA Margin stood at 36.18% in 2021, then tumbled by -160bps to 94.25% in 2022, then surged by 80bps to 18.87% in 2023, then plummeted by -2026bps to 401.05% in 2024, then skyrocketed by 64bps to 143.29% in 2025.
  • Per Business Quant, the three most recent readings for HCTI's EBITDA Margin are 143.29% (Q4 2025), 54.46% (Q3 2025), and 38.19% (Q2 2025).